{"id":"W4212936557","doi":"10.1200/jco.2022.40.6_suppl.521","title":"First-line pembrolizumab in advanced urothelial carcinoma: Clinical parameters associated with efficacy in the phase 2 KEYNOTE-052 and phase 3 KEYNOTE-361 trials.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Urothelial carcinoma; Pembrolizumab; Population; Clinical trial; Multivariate analysis; Logistic regression; Univariate analysis; Cisplatin; Proportional hazards model; Exploratory analysis; Cancer; Chemotherapy; Bladder cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005438468,0.000552751,0.000806944,0.0003483009,0.0002127759,0.001034205,0.0004817705,0.0006808583,0.002423411],"category_scores_gemma":[0.005769922,0.0002633945,0.001172611,0.0005889056,0.0002490145,0.0008634634,0.0004599236,0.001208443,0.0003484852],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005639002,"about_ca_system_score_gemma":0.0009370811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003253245,"about_ca_topic_score_gemma":0.0008213381,"domain_scores_codex":[0.9987215,0.0008046306,0.0001016157,0.000160643,0.0001007398,0.0001107193],"domain_scores_gemma":[0.9964328,0.001295878,0.0015117,0.0001991658,0.0001393574,0.0004211457],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6785273,0.00457422,0.2224546,0.002013863,0.005754334,0.0001613497,0.000181271,0.002798052,0.008924777,0.0003109089,0.004060887,0.07023845],"study_design_scores_gemma":[0.1060427,0.09289818,0.7718983,0.0003751089,0.007764921,0.0009196621,0.0001478799,0.005488627,0.004961409,0.0008064909,0.008591588,0.0001051025],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9822866,0.01183764,0.0005367433,0.0003502741,0.00004782536,0.0007321789,0.003020751,0.00003346737,0.00115448],"genre_scores_gemma":[0.9942353,0.0009188299,0.0006649009,0.0001585807,0.00005332309,0.0003902832,0.003180501,0.000006328117,0.000391839],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005438468,"threshold_uncertainty_score":0.02876168,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.213848007729113,"score_gpt":0.5081010446714576,"score_spread":0.2942530369423445,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}